• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病筛查:美国预防服务工作组推荐声明。

Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement.

机构信息

U.S. Preventive Services Task Force, Rockville, MD, USA.

出版信息

Ann Intern Med. 2012 Oct 16;157(8):567-70. doi: 10.7326/0003-4819-157-8-201210160-00533.

DOI:10.7326/0003-4819-157-8-201210160-00533
PMID:22928170
Abstract

DESCRIPTION

New U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for chronic kidney disease (CKD).

METHODS

The USPSTF reviewed evidence on screening for CKD, including evidence on screening, accuracy of screening, early treatment, and harms of screening and early treatment.

POPULATION

This recommendation applies to asymptomatic adults without diagnosed CKD. Testing for and monitoring CKD for the purpose of chronic disease management (including testing and monitoring patients with diabetes or hypertension) are not covered by this recommendation.

RECOMMENDATION

The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of routine screening for CKD in asymptomatic adults (I statement).

摘要

描述

美国预防服务工作组(USPSTF)关于慢性肾脏病(CKD)筛查的新建议声明。

方法

USPSTF 审查了 CKD 筛查的证据,包括筛查、筛查准确性、早期治疗以及筛查和早期治疗的危害的证据。

人群

本建议适用于无症状的无诊断 CKD 的成年人。本建议不包括出于慢性病管理目的(包括对患有糖尿病或高血压的患者进行检测和监测)的 CKD 的检测和监测。

建议

USPSTF 的结论是,证据不足以评估在无症状成年人中常规筛查 CKD 的利弊平衡(I 声明)。

相似文献

1
Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement.慢性肾脏病筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Oct 16;157(8):567-70. doi: 10.7326/0003-4819-157-8-201210160-00533.
2
Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.妊娠期糖尿病筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Mar 18;160(6):414-20. doi: 10.7326/M13-2905.
3
Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement.成人踝臂指数用于外周动脉疾病和心血管疾病风险评估的筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2013 Sep 3;159(5):342-8. doi: 10.7326/0003-4819-159-5-201309030-00008.
4
Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement.筛查甲状腺功能障碍:美国预防服务工作组推荐声明。
Ann Intern Med. 2015 May 5;162(9):641-50. doi: 10.7326/M15-0483.
5
Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement.儿童和青少年原发性高血压筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2013 Nov 5;159(9):613-9. doi: 10.7326/0003-4819-159-9-201311050-00725.
6
Screening for glaucoma: U.S. Preventive Services Task Force Recommendation Statement.青光眼筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2013 Oct 1;159(7):484-9. doi: 10.7326/0003-4819-159-6-201309170-00686.
7
Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement.膀胱癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2011 Aug 16;155(4):246-51. doi: 10.7326/0003-4819-155-4-201108160-00008.
8
Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement.口腔癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Jan 7;160(1):55-60. doi: 10.7326/M13-2568.
9
Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement.无症状颈动脉狭窄筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Sep 2;161(5):356-62. doi: 10.7326/M14-1333.
10
Screening for coronary heart disease with electrocardiography: U.S. Preventive Services Task Force recommendation statement.心电图筛查冠心病:美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Oct 2;157(7):512-8. doi: 10.7326/0003-4819-157-7-201210020-00514.

引用本文的文献

1
Balancing Efficiency and Equity in Population-Wide CKD Screening.在全人群慢性肾脏病筛查中平衡效率与公平性
JAMA Netw Open. 2025 Apr 1;8(4):e254740. doi: 10.1001/jamanetworkopen.2025.4740.
2
Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis.代谢功能障碍相关脂肪性肝病增加慢性肾脏病风险:一项系统评价和荟萃分析
eGastroenterology. 2023 Aug 7;1(1):e100005. doi: 10.1136/egastro-2023-100005. eCollection 2023 Jun.
3
Chronic kidney disease.慢性肾脏病
Nat Rev Dis Primers. 2025 Jan 30;11(1):8. doi: 10.1038/s41572-024-00589-9.
4
Populationwide Screening for Chronic Kidney Disease: A Cost-Effectiveness Analysis.人群慢性肾脏病筛查:成本效益分析。
JAMA Health Forum. 2024 Nov 1;5(11):e243892. doi: 10.1001/jamahealthforum.2024.3892.
5
Prevalence of undetected chronic kidney disease in high-risk middle-aged patients in primary care: a cross-sectional study.基层医疗中高危中年患者未被检测出的慢性肾脏病患病率:一项横断面研究
Front Med (Lausanne). 2024 Aug 13;11:1412689. doi: 10.3389/fmed.2024.1412689. eCollection 2024.
6
The Kidney in Obesity: Current Evidence, Perspectives and Controversies.肥胖与肾脏:现有证据、观点与争议
Curr Obes Rep. 2024 Dec;13(4):680-702. doi: 10.1007/s13679-024-00583-y. Epub 2024 Aug 14.
7
Bibliometric and visual analyses of advancements in chronic kidney disease management.对慢性肾脏病管理进展的文献计量和可视化分析。
Medicine (Baltimore). 2024 Jun 28;103(26):e38576. doi: 10.1097/MD.0000000000038576.
8
Examining chronic kidney disease screening frequency among diabetics: a POMDP approach.探讨糖尿病患者慢性肾脏病筛查频率:一种部分可观测马尔可夫决策过程方法。
Health Care Manag Sci. 2024 Sep;27(3):391-414. doi: 10.1007/s10729-024-09677-4. Epub 2024 Jun 5.
9
Framework of Guidelines for Management of CKD in Asia.亚洲慢性肾脏病管理指南框架
Kidney Int Rep. 2023 Dec 22;9(4):752-790. doi: 10.1016/j.ekir.2023.12.010. eCollection 2024 Apr.
10
Individualized Risk of CKD Progression among US Adults.美国成年人慢性肾脏病进展的个体化风险。
J Am Soc Nephrol. 2024 Aug 1;35(8):1076-1083. doi: 10.1681/ASN.0000000000000377. Epub 2024 May 15.